Polymorphisms in Toll-like receptor genes influence antibody responses to cytomegalovirus glycoprotein B vaccine

BACKGROUND: Congenital Cytomegalovirus (CMV) infection is an important medical problem that has yet no current solution. A clinical trial of CMV glycoprotein B (gB) vaccine in young women showed promising efficacy. Improved understanding of the basis for prevention of CMV infection is essential for...

Descripción completa

Detalles Bibliográficos
Autores principales: Arav-Boger, Ravit, Wojcik, Genevieve L, Duggal, Priya, Ingersoll, Roxann G, Beaty, Terri, Pass, Robert F, Yolken, Robert H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317442/
https://www.ncbi.nlm.nih.gov/pubmed/22414065
http://dx.doi.org/10.1186/1756-0500-5-140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317442/
https://www.ncbi.nlm.nih.gov/pubmed/22414065
http://dx.doi.org/10.1186/1756-0500-5-140

Ejemplares similares